TickerFacts.

Lftd Partners Inc. (LIFD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$1.47M
Year ended 2025-12-31
-$4.21M
Trailing 12 months to 2026-06-30
-47.3%
3-year compound annual growth
$10.00M2011-12-31: -$163.2K2012-12-31: -$1.21M2020-12-31: -$1.50M2021-12-31: $7.87M2022-12-31: $10.00M2023-12-31: $2.84M2024-12-31: -$252.8K2025-12-31: $1.47M$1.47M
2011-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$1.47Mn/m2026-04-01, From 2025-01-01
2024-12-31-$252.8Kn/m2026-04-01, From 2024-01-01
2023-12-31$2.84M-71.7%2026-04-01, From 2023-01-01
2022-12-31$10.00M+27.1%2025-03-31, From 2022-01-01
2021-12-31$7.87Mn/m2024-03-29, From 2021-01-01
2020-12-31-$1.50Mn/a2023-03-21, From 2020-01-01
No annual figure between 2012-12-31 and 2020-12-31.
2012-12-31-$1.21Mn/m2013-04-01, From 2012-01-01
2011-12-31-$163.2Kn/a2013-04-01, From 2011-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Lftd Partners Inc. (LIFD)2025-12-31$1.47Mn/m
Sunshine Biopharma Inc. (SBFM)2025-12-31-$5.89Mn/m
BGM Group Ltd. (BGM)2025-09-30-$11.12Mn/m
Bioharvest Sciences Inc. (BHST)2025-12-31-$3.95Mn/m
Biofrontera Inc. (BFRI)2025-12-31-$11.21Mn/m
Xilio Therapeutics, Inc. (XLO)2025-12-31-$40.44Mn/m
Foghorn Therapeutics Inc. (FHTX)2025-12-31-$83.06Mn/m
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$1.35Mn/m
Aquestive Therapeutics, Inc. (AQST)2025-12-31-$70.50Mn/m

Compare LIFD, SBFM, BGM, BHST side by side · Screen every company in Pharmaceutical Preparations ↗